Dose-escalating, phase 2 study of oral lisdexamfetamine in adults with methamphetamine dependence

Phase 2

Completed

• Conditions: Methamphetamine Dependence; Mental Health - Addiction

• Registration Number: ACTRN12615000391572
• Lead Sponsor: St. Vincent's Hospital, Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-04-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Treatment seeking for Methamphetamine (MA) dependence
- Fulfils ICD-10 criteria for MA dependence
- Self-reported MA use of >/= 14 days out of 28 days prior to enrolment

Exclusion Criteria

- Use of dexamphetamine in the previous 4 weeks
- Uncontrolled medical or psychiatric conditions
- Unstable alcohol or other substance use, other than MA
- Pregnant or nursing females
- Moderate to severe hypertension
- Sensitivity/allergy to lisdexamfetamine

Study & Design

• Study Type: Interventional
• Study Design: Not specified